Φορτώνει......
Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review
Cytomegalovirus (CMV) is a leading opportunistic infection in immune compromised patients, including allogeneic hematopoietic stem cell (HSCT) or solid organ transplant (SOT) recipients, where primary infection or reactivation is associated with increased morbidity and mortality. Antiviral drugs are...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Infect Drug Resist |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Dove
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6556539/ https://ncbi.nlm.nih.gov/pubmed/31239725 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S180908 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|